GAZZERRO, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 887
AS - Asia 218
EU - Europa 169
AF - Africa 8
Totale 1.282
Nazione #
US - Stati Uniti d'America 877
SG - Singapore 163
IT - Italia 103
CN - Cina 29
IN - India 21
NL - Olanda 13
SE - Svezia 11
CA - Canada 10
CI - Costa d'Avorio 8
DE - Germania 7
GB - Regno Unito 7
FR - Francia 5
UA - Ucraina 5
FI - Finlandia 4
PL - Polonia 4
BE - Belgio 3
IR - Iran 2
ME - Montenegro 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
CH - Svizzera 1
ID - Indonesia 1
IE - Irlanda 1
IL - Israele 1
RO - Romania 1
Totale 1.282
Città #
Chandler 235
Singapore 136
Ashburn 58
Lawrence 41
Millbury 37
Boston 35
Naples 33
Des Moines 28
Santa Clara 19
Rome 18
Wilmington 17
Amsterdam 12
Ottawa 10
Nanjing 8
Pune 8
Washington 6
Formia 5
Torre del Greco 5
Augusta 4
Fairfield 4
Napoli 4
New Delhi 4
Woodbridge 4
Arzano 3
Hebei 3
Ardabil 2
Beijing 2
Bengaluru 2
Boscoreale 2
Brussels 2
Chatsworth 2
Coperchia 2
Dallas 2
Duisburg 2
Kronberg 2
Leawood 2
Podgorica 2
Princeton 2
Salerno 2
San Mateo 2
Slough 2
Sovico 2
Varedo 2
Warsaw 2
Bergamo 1
Capaccio 1
Carbonara di Nola 1
Catania 1
Cava de' Tirreni 1
Changsha 1
Changzhou 1
Charleston 1
Charlotte 1
Courcelles 1
Credaro 1
Dhaka 1
Dublin 1
Edinburgh 1
Ercolano 1
Forest City 1
Gurgaon 1
Helsinki 1
Jiaxing 1
Lappeenranta 1
Los Angeles 1
Luhansk 1
Milan 1
Mumbai 1
New Orleans 1
Norwalk 1
Pescara 1
Redwood City 1
Santa Maria A Vico 1
Sciacca 1
Seattle 1
Shanghai 1
Shenyang 1
Sofia 1
Tel Aviv 1
Tirana 1
Torregrotta 1
Zurich 1
Totale 813
Nome #
N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression 49
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. 46
Antiangiogenic activity of the endocannabinoid anandamide. Correlation to its tumour-suppressor efficacy 42
The isoprenoid derivative N6-benzyladenosine (CM223) exerts antitumor effect in glioma patient-derived primary cells through the mevalonate pathway 41
Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer 40
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 37
Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis 37
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives 37
Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects 35
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells 35
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells 35
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 34
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 33
The endocannabinoid system: A target for cancer treatment 33
N6-isopentenyladenosine inhibits colorectal cancer and improves sensitivity to 5-fluorouracil-targeting FBXW7 tumor suppressor 33
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition. [*Pagano C. first author] 32
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth 32
Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review) 30
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake 30
Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression 30
Cannabinoids and cancer: pros and cons of an antitumour strategy 29
Advances in “adiponcosis”: Insights in the inner mechanisms at the base of adipose and tumour tissues interplay [*Pagano C. *Bifulco M. co-corrisponding authors] [*Pagano C. first author] 29
Update on the endocannabinoid system as an anticancer target 28
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer" 27
Il danno cellulare 27
The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed 27
NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity 27
The right to care and the expectations of society?controversial stem cell therapy in Italy 26
Pharmacological actions of statins: A critical appraisal in the management of cancer 26
Rimonabant-induced apoptosis in leukemia cell lines: Activation of caspase-dependent and -independent pathways 25
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells 24
Prdm12 in health and diseases 24
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation 24
Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects. (review) 23
Statins and cancer-related mortality: an open question 21
Association of alpha b-crystallin expression with tumor differentiation grade in colorectal cancer patients. [*Pagano C. first author] 21
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 20
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 20
Multifaceted role of PRDM proteins in human cancer 19
Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019 19
Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins 18
Association between Cannabinoid type-1 receptor polymorphism and body mass index in a Southern Italian population. Int J Obesity 18
In Vitro Evidence of Statins' Protective Role against COVID-19 Hallmarks 17
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 17
Statins and cancer in gastroenterology: new insight? 15
Oxylipins from Dracontium loretense 14
Statins in coronavirus outbreak: It's time for experimental and clinical studies 13
Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA Methyltransferases 12
Statin therapy in COVID-19 infection: Much more than a single pathway 11
Towards an improvement of anticancer activity of benzyl adenosine analogs 11
Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm 9
Synthesis and biological evaluation of Santacruzamate-A based analogues 6
Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets 5
Rimonabant and Cannabidiol Rewrite the Interactions between Breast Cancer Cells and Tumor Microenvironment 4
RIZ2 at the crossroad of the EGF/EGFR signaling in colorectal cancer 3
Exploring the putative role of PRDM1 and PRDM2 transcripts as mediators of T lymphocyte activation 3
Totale 1.383
Categoria #
all - tutte 7.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 0 0 0 2 0 1 3 3
2020/2021105 0 2 6 0 0 0 60 12 3 2 15 5
2021/2022243 1 3 1 1 0 10 4 8 7 17 73 118
2022/2023497 52 71 6 37 55 45 1 55 118 17 30 10
2023/2024286 15 49 24 23 18 38 4 14 8 30 44 19
2024/2025210 71 70 0 33 36 0 0 0 0 0 0 0
Totale 1.383